Evaluation of life quality of patients with chronic hepatitis C.

O. P. Schevchenko-Makarenko, L. R. Schostakovych-Korets`ka, Z. O. Chykarenko, V. D. Tkachenko, O. O. Lisnicha

Abstract


The article presents the adap­tation data of the quality of life questionnaire (QOL) in patients with chronic viral hepatitis C (CVHC). Ball score of QOL of patients with CVHC was 5.09±1.04, 2nd group (with co-infection with HIV / HCV) - 4.60±1.13, control group - 5.92±0.52 (p<0.05)). The results of the analysis show that co-infection HIV / HCV is a serious problem for patients and significantly affects QOL. The use of the QOL questionnaire for chronic liver disease is a sensitive tool for measuring QOL in patients with CVHC and co-infection HIV / HCV. This informative and economical method can be implemented to assess the patient's health both at the group and individual levels in patients with chronic liver disease in the population ofUkraine.


Keywords


quality of life; chronic viral hepatitis C; co-infection HIV / HCV questionnaire; CLDQ

Full Text:

PDF

References


Vakalyuk IP, Drapchak IM. [Features of the cour­se of a permanent form of atrial fibrillation in patients with concomitant chronic diffuse inflammatory diseases of the liver on the background of prolonged warfarin therapy]. Halytskyy likarskyy visnyk. 2015;22(1):13-17. Ukrainian.

Khalafyan AA. [Statistica 6. Statistical analysis: a manual for the higher educational institutions]. Moskva, Binom-Press. 2010;528. Russian.

Lekhan VM, Ipatov AV, Huk AP, Zyukov OL. [Quality of life in medical research]. Visnyk sotsialnoyi hihiyeny ta orhanizatsiyi okhorony zdoroviya Ukrayiny. 2004;1:57-61. Ukrainian.

Shevchenko-Makarenko ОP, Shostakovych-Ko­retskaya LR, Semiletova VV, et al. [Quality of life in HIV-infected patients with different comorbid patho­logical conditions]. Preventive medicine. 2016;3-4(27):168-9. Ukrainian.

Matsushita H, Ikeda F, Iwasaki Y, et al. Asses­sment of health-related quality of life and how it predicts the out­come of pegylated interferon and ribavirin therapy for chro­nic hepatitis C. J Gastroenterol Hepatol. 2014;29:337-43.

Younossi ZM, Guyatt G, Kiwi M, et al. Deve­lopment of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999;45:295-300.

Kallman J, O’Neil MM, Larive B, et al. Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection. Dig Dis Sci. 2007;52:2531–9.

Hollander A, Foster GR, Weiland O. Health-re­lated quality of life before, during and after combination therapy with interferon and ribavirin in unselected Swedish patients with chronic hepatitis C. Scand J Gas­troenterol. 2006;41:577-85.

Shevchenko-Makarenko О, Shostakovych-Ko­ret­skaya L, Timofeeva L. Quality of life in patients with HCV/ HIV co-infection. Reviews in Antiviral Therapy & Infectious diseases, 2016;9:9.

Schulz KH, Kroencke S, Ewers H, et al. The factorial structure of the Chronic Liver Disease Ques­tionnaire (CLDQ). Qual Life Res. 2008;17:575-84.

Popovic DDJ,KovacevicNV, Kisic Tepavcevic DB et al. Validation of the chronic liver disease ques­tionnaire in Serbian patients. World J Gastroenterol. 2013;19:4950-57.

Wells GA, Russell AS, Haraoui B, et al. Validity of quality of life measurement tools - from generic to disease-specific. J Rheumatol Suppl. 2011;88:2-6.

Ware JE. Interpreting SF–36 summary health measures: a response. Quality of life research, 2001;10(5):405-13.

Younossi ZM, Boparai N, McCormick M. A di­sease-specific health-related quality of life instrument for chronic hepatitis C: CLDQ-HCV. Hepatology. 2000;32:838.

Younossi ZM, Stepanova M, Henry L. Perfo­rmance and Validation of Chronic Liver Disease Ques­tionnaire-Hepatitis C Version (CLDQ-HCV) in Clinical Trials of Patients with Chronic Hepatitis C. Value Heals. 2016;19(5):544-51. doi: 10.1016/j.jval.2016.02.005. Epub 2016 Apr 26.


GOST Style Citations


  1. Вакалюк І.П. Особливості перебігу постійної форми фібриляції передсердь у хворих із супутніми хронічними дифузними запальними захворюваннями печінки на фоні тривалої варфаринотерапії / І.П. Ва­калюк, І.М. Драпчак // Галицький лікарський вісник. – 2015. – Т. 22, № 1. – С. 13-17.
  2. Халафян А.А. Statistica 6. Статистический ана­лиз данных: учеб. пособие для вузов / А.А. Халафян. – 2-е изд., перераб. и доп. – Москва: Бином-Пресс, 2010. – 528 с.
  3. Якість життя в медичних дослідженнях / В.М. Лехан, А.В. Іпатов, А.П. Гук, О.Л. Зюков // Віс­ник соціальної гігієни та організації охорони здоров’я України. – 2004. – № 1. – С. 57-61.
  4. Якість життя у ВІЛ-інфікованих пацієнтів при різних коморбідних патологіях / Л.Р. Шостакович-Корецька, О.П. Шевченко-Макаренко, В.В. Семіле­това [та ін.] // Профілактична медицина. – 2016. – № 3-4 (27), додаток. – С. 168-169.
  5. Assessment of health-related quality of life and how it predicts the outcome of pegylated interferon and ribavirin therapy for chronic hepatitis / H. Matsushita, F. Ikeda, Y. Iwasaki [et al.] // J. Gastroenterol Hepatol. – 2014. – Vol. 29. – P. 337-343.
  6. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease / Z.M. Younossi, G. Guyatt, M. Kiwi [et al.] // Gut. – 1999. – Vol. 45. – Р. 295-300.
  7. Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection / J. Kallman, M.M. O’Neil, B. Larive [et al.] // Dig. Dis. Sci. – 2007. – Vol. 52. – P.2531-2539.
  8. Hollander A. Health-related quality of life before, during and after combination therapy with interferon and ribavirin in unselected Swedish patients with chronic hepatitis C / A. Hollander, G.R.  Foster, O. Weiland // Scand. J. Gastroenterol. – 2006. – Vol. 41. – С. 577-585.
  9. Shevchenko-Makarenko О. Quality of life in pa­tients with HCV/ HIV co-infection / О. Shevchenko-Ma­karenko, L. Shostakovych-Koretskaya, L. Timofeeva // Reviews in Antiviral Therapy & Infectious diseases. – 2016. – Vol. 9. – P. 9.
  10. The factorial structure of the Chronic Liver Di­sease Questionnaire (CLDQ) / K.H. Schulz, S. Kroencke, Ewers H. [et al.] // Qual. Life. Res. – 2008. – N 17. – P. 575-584.
  11. Validation of the chronic liver disease question­naire in Serbian patients / D.D.J. Popovic, N.V. Kovacevic, D.B. Kisic Tepavcevic [et al.] // World J. Gastroenterol. – 2013. – N 19. – P. 4950-4957.
  12. Validity of quality of life measurement tools—from ge­neric to disease-specific / G.A. Wells, A.S. Rus­sell, B. Ha­raoui [et al.] // J. Rheumatol. Suppl.- 2011.- Vol. 88. – Р. 2-6.
  13. Ware J.E. Interpreting SF–36 summary health measures: a response / J.E. Ware. // Quality of life re­search. – 2001. – Vol. 10, N 5. – Р. 405-413.
  14. Younossi Z.M. A disease-specific health-related quality of life instrument for chronic hepatitis C: CLDQ-HCV / Z.M. Younossi,N. Boparai, M. McCormick // Hepatology. – 2000. – Vol. 32. – Р. 838.
  15. Younossi Z.M. Performance and Validation of Chronic Liver Disease Questionnaire-Hepatitis C Version (CLDQ-HCV) in Clinical Trials of Patients with Chronic Hepatitis C / Z.M. Younossi, M. Stepanova, L. Henry // Value Heals. – 2016. – Vol. 19, N 5. – Р. 544-551. doi: 10.1016/j.jval.2016.02.005. Epub 2016 Apr 26.




DOI: https://doi.org/10.26641/2307-0404.2017.4.117677

Refbacks

  • There are currently no refbacks.